Get informed when a big investor buys or sells
+ Follow38454.30
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Eastwood Bio-Medical Canada's peg ratio stands at 38454.3. That is above the sector sector average of -0.06. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Eastwood Bio-Medical Canada sits higher the its sector benchmark (-0.06) with a PEG ratio of 38454.3. That is roughly 65667298.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 38454.3 is attractive depends on Eastwood Bio-Medical Canada's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Eastwood Bio-Medical Canada's PEG ratio evolved across reporting periods, while the comparison chart places EWOOF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.